Clinical Trial Update: A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis [Phase 4]

View source ↗

Summary

A Phase 4 randomized, open-label, multicenter trial compares a precision treatment regimen guided by clinical-molecular phenotypes with conventional therapy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Takayasu Arteritis | Phase 4 | Status: RECRUITING